Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/23/2003WO2003086436A1 Enteric fat absorption inhibitors contaiing plant extract and foods containing the same
10/23/2003WO2003086433A1 Therapeutic cream for dermatitis
10/23/2003WO2003086432A1 Therapeutic lotion for dermatitis
10/23/2003WO2003086430A2 Medicinal herbal extract carpediol for treating depression
10/23/2003WO2003086428A1 Active substance mixtures of extracts of the genus vaccinium and carotene compounds
10/23/2003WO2003086425A1 An anti-rheumatism medicament and method to prepare thereof
10/23/2003WO2003086424A1 Pharmaceutical composition comprising arsenite for the treatment of malignancy
10/23/2003WO2003086422A1 Remedies
10/23/2003WO2003086421A1 External preparations for enhancing cell activity
10/23/2003WO2003086420A1 Use of acarbose and the derivatives thereof for the treatment and prophylaxis of degenerative skin conditions
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086418A1 Methods for the treatment of cancer
10/23/2003WO2003086417A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system
10/23/2003WO2003086415A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003WO2003086414A1 Structural modification of resveratrol: sodium resverastatin phosphate
10/23/2003WO2003086413A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
10/23/2003WO2003086412A2 Polyphosphonate derivatives for toothpaste compositions
10/23/2003WO2003086411A1 Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
10/23/2003WO2003086410A1 Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent
10/23/2003WO2003086409A1 The use of devazepide as analgesic agent
10/23/2003WO2003086408A1 Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
10/23/2003WO2003086407A1 Use of stimulators of soluble guanylate cyclase for treating glaucoma
10/23/2003WO2003086406A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003086405A1 Solid dispersion composition
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086401A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086399A1 Medicaments containing steroids and a novel anticholinesterase drug
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086393A1 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
10/23/2003WO2003086392A2 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003WO2003086391A1 New use
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086389A1 Use of a photosensitising compound for the preparation of a pharmaceutical composition for treating of burns, and a method of treating burns
10/23/2003WO2003086388A1 Estrogen receptor modulators
10/23/2003WO2003086387A1 Stable tablets comprising simvastatin
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003086384A1 Stabilized ascorbic acid derivatives
10/23/2003WO2003086383A1 Non-toxic amounts of protein-aggregating substances stimulate hsp70 expression and function as anti-tumor agents
10/23/2003WO2003086382A1 Tnp-470 polymer conjugates and use thereof
10/23/2003WO2003086381A1 Ansamycin formulations and methods for producing and using same
10/23/2003WO2003086380A1 Ptx3 gene expression suppressing method
10/23/2003WO2003086379A1 Treatment of neural injury and neurodegenerative disease with statins
10/23/2003WO2003086378A1 Preventive or therapeutic composition for colitis and large bowel cancer
10/23/2003WO2003086377A1 Amide derivatives
10/23/2003WO2003086376A1 Patch and process for producing the same
10/23/2003WO2003086375A1 Delivery systems for biologically active agents
10/23/2003WO2003086374A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086372A2 Methods of treating medication-, substance-, disease-, and other medical condition-related sexual dysfunction
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086370A1 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers
10/23/2003WO2003086368A1 Liquid compositions for soft sustained-release capsules and method for production thereof
10/23/2003WO2003086367A1 Low dose liquid entecavir formulations and use
10/23/2003WO2003086366A1 An improved modified release preparation
10/23/2003WO2003086365A1 Analgesical oral composition with controlled release of an opioid
10/23/2003WO2003086364A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003WO2003086363A1 Drug-complex microparticles and methods of making/using same
10/23/2003WO2003086362A2 Method of stabilizing bupropion hydrochloride tablets
10/23/2003WO2003086361A1 Rapidly dispersing solid oral compositions
10/23/2003WO2003086359A1 Tea polyphenol buccal tablet for preventing and treating tooth decay and its preparing method
10/23/2003WO2003086357A1 Diphenhydramine tannate liquid and semi-solid compositions and methods of use
10/23/2003WO2003086356A1 Diphenhydramine tannate solid dose compositions and methods of use
10/23/2003WO2003086355A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
10/23/2003WO2003086354A1 Nanoparticulate megestrol formulations
10/23/2003WO2003086353A1 Sustained release metoprolol formulations
10/23/2003WO2003086352A1 Pharmaceutical formulation comprising melatonin
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086350A1 Formoterol and mometasone aerosol formulations
10/23/2003WO2003086349A1 Formoterol and ciclesonide aerosol formulations
10/23/2003WO2003086348A1 Allergic dermatitis formulation and method of treatment
10/23/2003WO2003086346A1 Diphenhydramine tannate compositions and methods of use
10/23/2003WO2003086344A1 Antibiotic product, use and formulation thereof
10/23/2003WO2003086341A2 Aminophenylbenzothiazole compounds
10/23/2003WO2003086334A1 Hair growth tonic
10/23/2003WO2003086325A2 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086321A2 Modified release minerals
10/23/2003WO2003086318A2 Improved prodrugs of cc-1065 analogs
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086312A2 Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086305A2 Biodegradable peg-based polymer formulations in ocular applications
10/23/2003WO2003086303A2 Farnesoid x-activated receptor agonists
10/23/2003WO2003086302A2 Propagermanium for treating myeloma bone disease and other bone disorders
10/23/2003WO2003086298A2 Use of interleukin-19 to treat ovarian cancer
10/23/2003WO2003086295A2 Process for preparing tannate liquid and semi-solid dosage forms
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086293A2 Pharmaceutical preparation for taste masking
10/23/2003WO2003086291A2 Urea compositions
10/23/2003WO2003086288A2 Bicyclic amides
1 ... 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 ... 7860